drugset / Trial / NCT04128137

Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension

NCT04128137

Phase 4 Unknown 90 enrolled H.A.C. PHARMA
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy of a 4-week fludrocortisone (FLU) treatment on systolic blood pressure depression after 5 minutes of active orthostatism in patients with neurogenic orthostatic hypotension (HON) symptomatic, despite treatment with non-drug measures with or without midodrine.

Timeline

Start
2020-07-09
Primary completion
2024-06
Completion
2024-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fludrocortisone Other / unclassified 200 ug